Form D · Biotechnology
OrphoMed, Inc.
Mill Valley, CA · CIK 0001650809
Offering snapshot reported May 24, 2017 · SEC filing
- Reported sold
- $21.8M Offering amount: $39.3M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 8, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2017 | Initial | $21,772,377 | No comparison | 17 | SEC filing |
| Jan 15, 2016 | Amendment | $2,816,012 | $1,049,692vs Aug 13, 2015 | 10 | SEC filing |
| Aug 13, 2015 | Initial | $1,766,320 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-287373
Total Amount Sold includes $4,272,378 in total principal and interest converted from convertible promissory notes.
Source: Form D, filed May 24, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Chao | Director |
| Thomas D. Kiley | Director |
| Michael Martin | Director |
| Art Pappas | Director |
| Nikhilesh Singh | Director, Executive |
| Nikhilesh Singh, Ph.D. | Director, Executive |
| Frank Torti | Director |
| Kenneth Widder | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
806 Denise Court
Mill Valley, CA, 94941
Mill Valley, CA, 94941